Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I
Emil Kakkis(BioMarin (United States)), Merry Passage(University of California, Los Angeles), Patricia Dickson(Washington University in St. Louis), Michael F. McEntee(Knoxville College), Pavel V. Belichenko(Stanford University), Si-Hung Le(UCLA Medical Center), Beth Levy(Saint Louis University), Carole Vogler(University of Washington), Stephen R. Hanson(Oregon Health & Science University), William C. Mobley(University of California San Diego)
Cited by 168
Related Papers
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
AAV Vector Integration Sites in Mouse Hepatocellular Carcinoma
|Science|2007|648
Three dimensional optical angiography
|Optics Express|2007|631
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020
|Journal of the National Comprehensive Cancer Network|2020|507
Enabling Technologies for Personalized and Precision Medicine
|Trends in biotechnology|2020|483